Go Pro

National Research (NRC) Stock Price, News & Analysis

National Research logo
$21.19 -0.12 (-0.56%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$21.19 0.00 (0.00%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About National Research Stock (NASDAQ:NRC)

Advanced

Key Stats

Today's Range
$20.84
$21.82
50-Day Range
$17.75
$22.77
52-Week Range
$11.01
$23.68
Volume
142,811 shs
Average Volume
112,016 shs
Market Capitalization
$481.99 million
P/E Ratio
84.76
Dividend Yield
3.02%
Price Target
$26.00
Consensus Rating
Hold

Company Overview

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada. The company has evolved from traditional survey services to a comprehensive suite of analytics solutions, including market performance benchmarking, predictive modeling and customized reporting dashboards.

Key products and services include patient experience measurement solutions that track and benchmark patient perceptions, employee engagement surveys designed to identify workforce trends, and post-discharge outreach that aids in care coordination and readmission reduction. NRC Health also offers advisory services to help healthcare organizations interpret data, implement best practices and monitor the impact of improvement efforts.

National Research is overseen by a board of directors and managed by a team of senior executives with extensive backgrounds in healthcare quality, data science and information technology. The company maintains strategic partnerships with provider associations and research institutions to advance the use of patient-reported outcomes and analytics-driven decision-making in the healthcare industry.

AI Generated. May Contain Errors.

National Research Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

NRC MarketRank™: 

National Research scored higher than 62% of companies evaluated by MarketBeat, and ranked 343rd out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    National Research has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    National Research has a consensus price target of $26.00, representing about 22.7% upside from its current price of $21.19.

  • Amount of Analyst Coverage

    National Research has only been the subject of 2 research reports in the past 90 days.

  • Read more about National Research's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of National Research is 84.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 45.34.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of National Research is 84.76, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 269.06.

  • Price to Book Value per Share Ratio

    National Research has a P/B Ratio of 73.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about National Research's valuation and earnings.
  • Percentage of Shares Shorted

    2.49% of the float of National Research has been sold short.
  • Short Interest Ratio / Days to Cover

    National Research has a short interest ratio ("days to cover") of 5.37.
  • Change versus previous month

    Short interest in National Research has recently decreased by 1.09%, indicating that investor sentiment is improving.
  • Dividend Yield

    National Research pays a meaningful dividend of 3.00%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    National Research does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of National Research is 256.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about National Research's dividend.
  • News Sentiment

    National Research has a news sentiment score of 1.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for National Research this week, compared to 1 article on an average week.
  • MarketBeat Follows

    4 people have added National Research to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, National Research insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    9.20% of the stock of National Research is held by insiders.

  • Percentage Held by Institutions

    47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about National Research's insider trading history.
Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NRC Stock News Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
National Research: Q2 Earnings Snapshot
NRC Health (NRC) Q2 2026 Earnings Call Transcript
NRC Health Announces Second Quarter 2026 Results
See More Headlines

NRC Stock Analysis - Frequently Asked Questions

National Research's stock was trading at $18.77 at the beginning of the year. Since then, NRC stock has increased by 12.9% and is now trading at $21.19.

National Research Corporation (NASDAQ:NRC) issued its earnings results on Tuesday, July, 28th. The company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.46. The company had revenue of $35.39 million for the quarter, compared to analyst estimates of $34.90 million. National Research had a net margin of 4.18% and a trailing twelve-month return on equity of 164.26%.
Read the conference call transcript
.

National Research subsidiaries include these companies: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada.

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM).

Company Calendar

Record date for 7/10 Dividend
6/26/2026
Ex-Dividend for 7/10 Dividend
6/26/2026
Dividend Payable
7/10/2026
Last Earnings
7/28/2026
Today
8/14/2026
Record date for 10/9 Dividend
9/25/2026
Ex-Dividend for 10/9 Dividend
9/25/2026
Dividend Payable
10/09/2026
Next Earnings (Estimated)
10/26/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
NASDAQ:NRC
CIK
70487
Employees
490
Year Founded
1981

Price Target and Rating

High Price Target
$26.00
Low Price Target
$26.00
Potential Upside/Downside
+22.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.25
Trailing P/E Ratio
84.76
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$11.60 million
Net Margins
4.18%
Pretax Margin
6.70%
Return on Equity
164.26%
Return on Assets
14.67%

Debt

Debt-to-Equity Ratio
13.13
Current Ratio
0.65
Quick Ratio
0.65

Sales & Book Value

Annual Sales
$140.00 million
Price / Sales
3.44
Cash Flow
$1.25 per share
Price / Cash Flow
16.95
Book Value
$0.29 per share
Price / Book
73.07

Miscellaneous

Outstanding Shares
22,746,000
Free Float
20,653,000
Market Cap
$481.99 million
Optionable
Optionable
Beta
0.34

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:NRC) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners